John Battaglia

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Pharmacological management of acute agitation
    John Battaglia
    Department of Psychiatry and Behavioural Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Drugs 65:1207-22. 2005
  2. ncbi request reprint Calming versus sedative effects of intramuscular olanzapine in agitated patients
    John Battaglia
    University of Wisconsin Medical School, Madison, WI, USA
    Am J Emerg Med 21:192-8. 2003
  3. ncbi request reprint Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment
    Padraig Wright
    Clinical Neuroscience, Lilly Research Centre, Eli Lilly and Company, Surrey, UK
    Can J Psychiatry 48:716-21. 2003
  4. ncbi request reprint Best clinical practice with ziprasidone IM: update after 2 years of experience
    Dan L Zimbroff
    Pacific Clinical Research Medical Group, Upland, California 91786, USA
    CNS Spectr 10:1-15. 2005
  5. ncbi request reprint A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia
    John Battaglia
    Program of Assertive Community Treatment, Madison, WI 53703, USA
    Clin Ther 27:1612-8. 2005

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Pharmacological management of acute agitation
    John Battaglia
    Department of Psychiatry and Behavioural Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Drugs 65:1207-22. 2005
    ..These intramuscular atypical antipsychotics may represent a historical advance in the treatment of acute agitation...
  2. ncbi request reprint Calming versus sedative effects of intramuscular olanzapine in agitated patients
    John Battaglia
    University of Wisconsin Medical School, Madison, WI, USA
    Am J Emerg Med 21:192-8. 2003
    ....
  3. ncbi request reprint Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment
    Padraig Wright
    Clinical Neuroscience, Lilly Research Centre, Eli Lilly and Company, Surrey, UK
    Can J Psychiatry 48:716-21. 2003
    ..To determine the antipsychotic efficacy and extrapyramidal safety of intramuscular (i.m.) olanzapine and i.m. haloperidol during the first 24 hours of treatment of acute schizophrenia...
  4. ncbi request reprint Best clinical practice with ziprasidone IM: update after 2 years of experience
    Dan L Zimbroff
    Pacific Clinical Research Medical Group, Upland, California 91786, USA
    CNS Spectr 10:1-15. 2005
    ..Additional trials of ziprasidone IM in agitated patients in a variety of clinical setting are warranted to generate comparative risk/benefit data with conventional agents and other second-generation antipsychotics...
  5. ncbi request reprint A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia
    John Battaglia
    Program of Assertive Community Treatment, Madison, WI 53703, USA
    Clin Ther 27:1612-8. 2005
    ..Acutely agitated patients with schizophrenia might require treatment with IM antipsychotics, followed by a transition to oral medication...